Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

McKesson Corporation : McKesson and Epic Settle Patent Infringement Litigation

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/04/2013 | 08:11pm CET


Settlement allows companies to focus on needs of customers

SAN FRANCISCO, March 4, 2013 - McKesson Corporation and Epic Systems Corporation have settled their longstanding patent infringement litigation involving McKesson's U.S. patent #6,757,898 and Epic's MyChart software. 

Under terms of the settlement, McKesson agreed to grant Epic a license to the patent for the benefit of Epic and its customers.  In exchange, Epic agreed that it will no longer contest the validity of the patent, allowing McKesson and Epic to return to normalcy in their relationship going forward.  The parties also agreed to dismiss all pending claims and counterclaims and end any further litigation and appeals.

Executives from both parties recognized the settlement as one that will benefit the healthcare industry in general, and allow both parties to focus on the needs of their customers. 

"We're delighted to have settled this litigation with McKesson," said Carl Dvorak, chief operating officer, Epic Systems Corporation.

"We look forward to reestablishing our prior relationship and exploring new opportunities to serve our mutual customers," echoed Jeff Felton, president of McKesson's RelayHealth business. "Both companies will benefit by putting this litigation behind us."

About McKesson Corporation

McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.www.mckesson.com.

PR Contact

Kris Fortner
415.983.8352
[email protected]



distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
02/22MCKESSON CORPORATION : Announces Pricing of Tender Offer
BU
02/22MCKESSON CORPORATION : Announces Early Tender Results
BU
02/21MCKESSON CORPORATION : Free Research Report as McKesson’s Quarterly Revenues Gre..
AC
02/21MCKESSON CORP : Creation of a Direct Financial Obligation or an Obligation under..
AQ
02/20MCKESSON : Five Things to Know About Value-Based Reimbursement
PU
02/15MCKESSON : Trademark Application for "CFAAS" Filed
AQ
02/13MCKESSON CORP : Creation of a Direct Financial Obligation or an Obligation under..
AQ
02/12MCKESSON : Strategies for Specialty Practices to Improve Their Performance
PU
02/09HOSPITAL INFORMATION SYSTEMS (HIS) M : Hospital Information Systems Market Overv..
AQ
02/08RATING ACTION : Moody's assigns Baa2 to McKesson's new Euro and US notes
AQ
More news
News from SeekingAlpha
02/23Tracking Larry Robbins' Glenview Capital Management Portfolio - Q4 2017 Updat.. 
02/22Upcoming Dividends; 89 Companies, 32 Increases, 14 Double-Digit Increases 
02/21Appleseed Fund Q4 2017 Quarterly Letter 
02/20Albertsons/Rite Aid tie-up positive for McKesson - Needham 
02/20WALL STREET BREAKFAST : Albertsons Scoops Up Rest Of Rite Aid 
Financials ($)
Sales 2018 208 B
EBIT 2018 3 460 M
Net income 2018 1 694 M
Debt 2018 4 102 M
Yield 2018 0,82%
P/E ratio 2018 18,54
P/E ratio 2019 15,05
EV / Sales 2018 0,17x
EV / Sales 2019 0,16x
Capitalization 31 186 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 182 $
Spread / Average Target 22%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-3.76%31 186
CVS HEALTH-5.16%69 653
WALGREENS BOOTS ALLIANCE-4.12%68 980
EXPRESS SCRIPTS HOLDING CO1.59%42 948
CARDINAL HEALTH12.31%21 655
AMERISOURCEBERGEN7.35%21 653